Jeanie Herbert | Head, Investor Relations & Corporate Communications |
Mark Foley | President & Chief Executive Officer |
Dustin Sjuts | Chief Commercial Officer, Aesthetics & Therapeutics |
Toby Schilke | Chief Financial Officer |
Abhay Joshi | Chief Operating Officer & President of R&D & Product Operations |
Terence Flynn | Goldman Sachs |
Stacy Ku | Cowen & Company |
David Amsellem | Piper Sandler |
Balaji Prasad | Barclays |
Tim Lugo | William Blair |
Tian Sun | Needham & Company |
Kushal Patel | Guggenheim |
Welcome to the Revance Therapeutics Second Quarter 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
Following managements' prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, today's call is being recorded today August 6th, 2020. I would now like to turn the call over to Jeanie Herbert, Head of Investor Relations and Corporate Communications for Revance.